Capstone Investment Advisors’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$690K Buy
57,370
+5,684
+11% +$67K ﹤0.01% 1189
2026
Q2
$554K Buy
51,686
+12,146
+31% +$93.9K ﹤0.01% 1194
2026
Q1
$252K Buy
+39,540
New +$275K ﹤0.01% 1432
2025
Q4
– Sell
-33,906
Closed -$186K – 1864
2025
Q3
$186K Buy
+33,906
New +$166K ﹤0.01% 1846
2021
Q3
– Sell
-15,000
Closed -$418K – 2041
2021
Q2
$418K Buy
+15,000
New +$396K ﹤0.01% 1419

Other funds holding LFST

Capstone Investment Advisors's LFST Position: Q3 2026 in Review

Capstone Investment Advisors increased its Lifestance Health (LFST) stake by 11% in Q3 2026, buying an estimated $67K and bringing the position to 57,370 shares worth $690K. The position accounts for ﹤0.01% of the portfolio, ranked #1189.

Capstone Investment Advisors first reported a position in LFST in Q2 2021 and has held it in 5 quarters since. 324 funds tracked by Wall St. Rank hold LFST as of Q3 2026.

  • Capstone Investment Advisors held 57,370 shares of Lifestance Health worth $690K as of Q3 2026.
  • Capstone Investment Advisors bought 5,684 Lifestance Health shares in Q3 2026, an estimated $67K.
  • Lifestance Health made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q3 2026, its #1189 holding.
  • Capstone Investment Advisors first reported a position in Lifestance Health in Q2 2021 and has held it in 5 quarters since.
  • 324 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2026.

Based on Capstone Investment Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.